MDC Translational Science and Clinical Research Grants Competition Opens for 2024-25

Muscular Dystrophy Canada’s annual Neuromuscular Research Grant Program is now open for 2024-25!

 

The annual Neuromuscular Research Grant Program invests in projects related to the diagnosis, treatment, or clinical care of neuromuscular disorders. These grants are intended to: fill gaps in the existing funding landscape; enable researchers to build new and innovative research; support proof-of-concept, feasibility and pilot studies in preparation for larger-scale, longer-term grants from external sources. MDC grants also facilitate partnerships between researchers and patients.

Two streams are available: Translational Science Grants and Clinical Research Grants

  • Application Open: September 3, 2024
  • Application Deadline: November 18, 2024 at 11:59 pm (ET)
  • Notice of Decision: March 3, 2025
  • Funding Start Date: April 1, 2025

MDC welcome research grants focused on one or multiple neuromuscular disorders (NMD). In this cycle, we especially encourage proposals focusing on Friedreich ataxia, Charcot-Marie-Tooth disease / hereditary motor and sensory neuropathies (HMSN), myotonic dystrophy, limb-girdle muscular dystrophy and collagen VI-related dystrophy.

Visit the MDC Translational Science and Clinical Research Grants webpage to learn more, or view the funding application guidelines here. For further inquiries, please contact Dr. Homira Osman, VP of Research and Public Policy, Muscular Dystrophy Canada at <>.

MDC-researchgrants-2025

Read next...

CIHR logo

Emerging Leaders Webinar and Workshop Series from the CIHR-Institute of Musculoskeletal Health and Arthritis

The Emerging Leaders Series at CIHR-IMHA is designed to support learning and career development for a new generation of equitable and inclusive leaders in health research.

NMD4C launches 2024-2025 NNLS

NMD4C Launch Third Annual Training Series for Clinical Neuromuscular Fellows

The NMD4C Clinical Research Curriculum Development team is pleased to share that the third annual National Neuromuscular Lecture Series began this past August.

2025 clinical and research fellowships competition from NMD4C and MDC.

2025 NMD4C and MDC Neuromuscular Fellowship Funding Competition Opens

Together with MDC we are excited to announce the opening of our 2025 annual funding competition to award postdoctoral fellowships in NMD research, and clinical fellowship awards in neuromuscular medicine and electromyography! 

RareKids-CAN logo

RareKids-CAN Offer Subsidized Services for Investigator-initiated Academic Clinical Trials

RareKids-CAN offers a range of subsidized services for investigator-initiated (academic-led) pediatric rare disease clinical trials.

Canada-reaches-100NBS_900px

100 percent of Canada is Now Screening Infants for Spinal Muscular Atrophy

We are excited to share that from August 20, 2024, all babies born in Canada can now be tested for spinal muscular atrophy (SMA), a potentially fatal neuromuscular disorder.

Western-Canadian-Neuromuscular-Conference

Western Canadian Neuromuscular Conference Accepting Scientific Abstracts for Research Symposium

Abstracts for the research symposium will be accepted until September 6, 2024. Please visit the WCNMC website for instructions on how to submit your abstract.